HOLX – Hologic, Inc.
Hologic, Inc.HOLX
$61.52Name : Hologic, Inc.
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $13,886,479,360.00
EPSttm : 3.16
Hologic, Inc.
$61.52
0.28%$0.17Float Short %
2.64
Margin Of Safety %
22
Put/Call OI Ratio
0.95
EPS Next Q Diff
0.07
EPS Last/This Y
0.91
EPS This/Next Y
0.36
Price
61.68
Target Price
79.07
Analyst Recom
2.48
Performance Q
-14.43
Relative Volume
1.88
Beta
0.54
Ticker: HOLX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-05 | HOLX | 62.07 | 0.80 | 3.07 | 9695 |
| 2025-03-06 | HOLX | 62.49 | 0.80 | 7.50 | 9673 |
| 2025-03-07 | HOLX | 64.56 | 0.81 | 0.14 | 9719 |
| 2025-03-10 | HOLX | 65.63 | 0.78 | 0.18 | 9982 |
| 2025-03-11 | HOLX | 62.6 | 0.77 | 1.13 | 10090 |
| 2025-03-12 | HOLX | 61.13 | 0.75 | 0.70 | 10289 |
| 2025-03-13 | HOLX | 60.73 | 0.75 | 0.40 | 10316 |
| 2025-03-14 | HOLX | 60.71 | 0.73 | 2.38 | 10204 |
| 2025-03-17 | HOLX | 61.83 | 0.73 | 0.07 | 10214 |
| 2025-03-18 | HOLX | 62 | 0.73 | 0.11 | 10206 |
| 2025-03-19 | HOLX | 61.49 | 0.73 | 0.22 | 10206 |
| 2025-03-20 | HOLX | 61.01 | 0.72 | 0.24 | 10104 |
| 2025-03-21 | HOLX | 61.43 | 0.71 | 0.77 | 10048 |
| 2025-03-24 | HOLX | 61.86 | 0.98 | 0.11 | 7588 |
| 2025-03-25 | HOLX | 60.79 | 0.96 | 0.04 | 7655 |
| 2025-03-26 | HOLX | 61.48 | 0.94 | 0.17 | 7685 |
| 2025-03-27 | HOLX | 62.31 | 0.94 | 0.30 | 7692 |
| 2025-03-28 | HOLX | 61.32 | 0.94 | 0.60 | 7716 |
| 2025-03-31 | HOLX | 61.77 | 0.94 | 0.31 | 7721 |
| 2025-04-01 | HOLX | 61.36 | 0.93 | 0.08 | 7764 |
| 2025-04-02 | HOLX | 60.55 | 0.92 | 2.74 | 7802 |
| 2025-04-03 | HOLX | 61.68 | 0.95 | 0.32 | 7964 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-05 | HOLX | 62.07 | -1.2 | 198.0 | 4.26 |
| 2025-03-06 | HOLX | 62.49 | -1.2 | 210.4 | 4.26 |
| 2025-03-07 | HOLX | 64.54 | -1.2 | 241.7 | 4.26 |
| 2025-03-10 | HOLX | 65.64 | -1.2 | 222.4 | 4.26 |
| 2025-03-11 | HOLX | 62.59 | -1.2 | 146.7 | 4.26 |
| 2025-03-12 | HOLX | 61.12 | -1.2 | 174.2 | 4.26 |
| 2025-03-13 | HOLX | 60.73 | -1.2 | 195.2 | 4.26 |
| 2025-03-14 | HOLX | 60.71 | -1.2 | 202.7 | 4.26 |
| 2025-03-17 | HOLX | 61.82 | -1.3 | 224.8 | 4.26 |
| 2025-03-18 | HOLX | 62.01 | -1.3 | 206.1 | 4.26 |
| 2025-03-19 | HOLX | 61.47 | -1.3 | 192.6 | 4.26 |
| 2025-03-20 | HOLX | 61.01 | -1.3 | 193.5 | 4.26 |
| 2025-03-21 | HOLX | 61.44 | -1.3 | 211.0 | 4.26 |
| 2025-03-24 | HOLX | 61.89 | -1.3 | 211.0 | 4.26 |
| 2025-03-25 | HOLX | 60.80 | -1.3 | 181.3 | 4.26 |
| 2025-03-26 | HOLX | 61.48 | -1.3 | 215.9 | 4.26 |
| 2025-03-27 | HOLX | 62.31 | -1.3 | 218.7 | 4.26 |
| 2025-03-28 | HOLX | 61.32 | -1.3 | 183.2 | 4.26 |
| 2025-03-31 | HOLX | 61.79 | -1.3 | 211.7 | 4.26 |
| 2025-04-01 | HOLX | 61.38 | -1.3 | 194.5 | 4.26 |
| 2025-04-02 | HOLX | 60.56 | -1.3 | 186.5 | 4.26 |
| 2025-04-03 | HOLX | 61.68 | -1.3 | 224.7 | 4.26 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-05 | HOLX | -1.30 | -1.71 | 2.66 |
| 2025-03-06 | HOLX | -1.30 | -1.71 | 2.66 |
| 2025-03-07 | HOLX | -1.29 | -1.71 | 2.66 |
| 2025-03-10 | HOLX | -1.29 | -1.34 | 2.66 |
| 2025-03-11 | HOLX | -1.29 | -1.34 | 2.66 |
| 2025-03-12 | HOLX | -1.29 | -1.34 | 2.00 |
| 2025-03-13 | HOLX | -1.29 | -1.34 | 2.00 |
| 2025-03-14 | HOLX | -1.29 | -1.34 | 2.00 |
| 2025-03-17 | HOLX | -1.27 | -1.19 | 2.00 |
| 2025-03-18 | HOLX | -1.27 | -1.19 | 2.00 |
| 2025-03-19 | HOLX | -1.27 | -1.19 | 2.00 |
| 2025-03-20 | HOLX | -1.27 | -1.19 | 2.00 |
| 2025-03-21 | HOLX | -1.27 | -1.19 | 2.00 |
| 2025-03-24 | HOLX | -1.27 | -1.19 | 2.00 |
| 2025-03-25 | HOLX | -1.27 | -1.19 | 2.00 |
| 2025-03-26 | HOLX | -1.27 | -1.19 | 2.64 |
| 2025-03-27 | HOLX | -1.27 | -1.19 | 2.64 |
| 2025-03-28 | HOLX | -1.27 | -1.19 | 2.64 |
| 2025-03-31 | HOLX | -1.27 | -1.18 | 2.64 |
| 2025-04-01 | HOLX | -1.27 | -1.18 | 2.64 |
| 2025-04-02 | HOLX | -1.27 | -1.18 | 2.64 |
| 2025-04-03 | HOLX | -1.27 | -1.18 | 2.64 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.03
Avg. EPS Est. Current Quarter
1.02
Avg. EPS Est. Next Quarter
1.1
Insider Transactions
-1.27
Institutional Transactions
-1.18
Beta
0.54
Average Sales Estimate Current Quarter
1000
Average Sales Estimate Next Quarter
1025
Fair Value
74.99
Quality Score
92
Growth Score
68
Sentiment Score
49
Actual DrawDown %
29.8
Max Drawdown 5-Year %
-30.9
Target Price
79.07
P/E
19.52
Forward P/E
13.29
PEG
2.53
P/S
3.43
P/B
2.92
P/Free Cash Flow
12.24
EPS
3.16
Average EPS Est. Cur. Y
4.26
EPS Next Y. (Est.)
4.62
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
18.42
Relative Volume
1.88
Return on Equity vs Sector %
-4.2
Return on Equity vs Industry %
7.2
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
224.7
Hologic, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 7063
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
stock quote shares HOLX – Hologic, Inc. Stock Price stock today
news today HOLX – Hologic, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch HOLX – Hologic, Inc. yahoo finance google finance
stock history HOLX – Hologic, Inc. invest stock market
stock prices HOLX premarket after hours
ticker HOLX fair value insiders trading